Medidata Solutions

Name: Medidata Solutions
Brand: Medidata

Leader

Powering Smarter Treatments and Healthier People

Est 1999|Valuation $5.8B|Raised $20M|44 Ref Customers

LinkedIn 117K|Web traffic 101K|FTEs 2,772|HQ New York, New York, US

01Competitive Landscape

Narrative analysis

Where Medidata appears to be positioned for strength: - Widespread familiarity at investigator sites, which can reduce site retraining burden. - Platform breadth: integration of EDC, CTMS, patient tools, and professional services. - Explicit security and compliance documentation and certifications available for review. Where alternatives may offer advantages: - Modern user experience and faster configuration are frequently cited strengths of newer EDC vendors. - Cost control for smaller sponsors: academic or lower-cost options (e.g., REDCap) may be more suitable when enterprise features are not required. Market adoption signals (non-exhaustive): - The vendor cites independent market research findings and competitor press indicates competing momentum in the EDC market. Buyers should interpret vendor-cited preference or leadership metrics alongside methodology details.

	Medidata (Rave EDC / platform)	Veeva Vault EDC	Medrio EDC
Starting Price	Not publicly listed; anecdotal reviewer comments exist about CTMS starting prices (anecdotal)	Not publicly listed (generally enterprise quote)	Not publicly listed (generally quote)
Best For	Large/global trials needing a mature EDC ecosystem and documented compliance posture; organizations seeking an integrated platform and professional services	Sponsors standardizing on the Veeva ecosystem and seeking modern study build/operations	Small–mid sponsors/CROs emphasizing usability and rapid configuration
Key Strength	Substantial market presence and a broad platform/modules offering; documented compliance certifications	Modern cloud platform design and momentum in study starts	Focus on usability and rapid configuration with no-code/low-code approaches
Key Weakness	User experience complaints (navigation, UI); session timeouts; cost for small organizations; support resolution time	Limited public pricing information; migration effort from legacy EDCs; requires fit with Veeva ecosystem	May be perceived as less suitable for some large global sponsors depending on enterprise requirements

01Competitive Landscape

Narrative analysis

Where Medidata appears to be positioned for strength:

Widespread familiarity at investigator sites, which can reduce site retraining burden.
Platform breadth: integration of EDC, CTMS, patient tools, and professional services.
Explicit security and compliance documentation and certifications available for review.

Where alternatives may offer advantages:

Modern user experience and faster configuration are frequently cited strengths of newer EDC vendors.
Cost control for smaller sponsors: academic or lower-cost options (e.g., REDCap) may be more suitable when enterprise features are not required.

Market adoption signals (non-exhaustive):

The vendor cites independent market research findings and competitor press indicates competing momentum in the EDC market. Buyers should interpret vendor-cited preference or leadership metrics alongside methodology details.

	Medidata (Rave EDC / platform)	Veeva Vault EDC	Medrio EDC
Starting Price	Not publicly listed; anecdotal reviewer comments exist about CTMS starting prices (anecdotal)	Not publicly listed (generally enterprise quote)	Not publicly listed (generally quote)
Best For	Large/global trials needing a mature EDC ecosystem and documented compliance posture; organizations seeking an integrated platform and professional services	Sponsors standardizing on the Veeva ecosystem and seeking modern study build/operations	Small–mid sponsors/CROs emphasizing usability and rapid configuration
Key Strength	Substantial market presence and a broad platform/modules offering; documented compliance certifications	Modern cloud platform design and momentum in study starts	Focus on usability and rapid configuration with no-code/low-code approaches
Key Weakness	User experience complaints (navigation, UI); session timeouts; cost for small organizations; support resolution time	Limited public pricing information; migration effort from legacy EDCs; requires fit with Veeva ecosystem	May be perceived as less suitable for some large global sponsors depending on enterprise requirements

Medidata Solutions

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map